Xuesong Liu
Cancer Research
Abbott Laboratories
Abbott Park
IL 60064
USA
Name/email consistency: high
- Acquired resistance to combination treatment with temozolomide and ABT-888 is mediated by both base excision repair and homologous recombination DNA repair pathways. Liu, X., Han, E.K., Anderson, M., Shi, Y., Semizarov, D., Wang, G., McGonigal, T., Roberts, L., Lasko, L., Palma, J., Zhu, G.D., Penning, T., Rosenberg, S., Giranda, V.L., Luo, Y., Leverson, J., Johnson, E.F., Shoemaker, A.R. Mol. Cancer Res. (2009)
- An enzyme-linked immunosorbent poly(ADP-ribose) polymerase biomarker assay for clinical trials of PARP inhibitors. Liu, X., Palma, J., Kinders, R., Shi, Y., Donawho, C., Ellis, P.A., Rodriguez, L.E., Colon-Lopez, M., Saltarelli, M., LeBlond, D., Lin, C.T., Frost, D.J., Luo, Y., Giranda, V.L. Anal. Biochem. (2008)
- Akt inhibitor a-443654 interferes with mitotic progression by regulating aurora a kinase expression. Liu, X., Shi, Y., Woods, K.W., Hessler, P., Kroeger, P., Wilsbacher, J., Wang, J., Wang, J.Y., Li, C., Li, Q., Rosenberg, S.H., Giranda, V.L., Luo, Y. Neoplasia (2008)
- Poly (ADP-ribose) polymerase activity regulates apoptosis in HeLa cells after alkylating DNA damage. Liu, X., Luo, X., Shi, Y., Zhu, G.D., Penning, T., Giranda, V.L., Luo, Y. Cancer Biol. Ther. (2008)
- Quantitative analysis of anti-apoptotic function of Akt in Akt1 and Akt2 double knock-out mouse embryonic fibroblast cells under normal and stressed conditions. Liu, X., Shi, Y., Birnbaum, M.J., Ye, K., De Jong, R., Oltersdorf, T., Giranda, V.L., Luo, Y. J. Biol. Chem. (2006)